Page 245 - IJB-9-6

International Journal of Bioprinting Bioprinting in diabetic foot disease

118. Wang M, Li W, Mille LS, et al., 2022, Digital light processing 131. Zhang X, Wang H, Du C, et al., 2022, Custom-molded
based bioprinting with composable gradients. Adv Mater, offloading footwear effectively prevents recurrence and
34(1): e2107038. amputation, and lowers mortality rates in high-risk diabetic
foot patients: A multicenter, prospective observational
119. Nuutila K, Samandari M, Endo Y, et al., 2021, In vivo printing study. Diabetes Metab Syndr Obes, 15(2022): 103–109.
of growth factor-eluting adhesive scaffolds improves wound
healing. Bioact Mater, 8(2021): 296–308. 132. Zhao Y, Zhong J, Wang Y, et al., 2023, Photocurable
and elastic polyurethane based on polyether glycol with
120. Biranje SS, Sun J, Cheng L, et al., 2022, Development of adjustable hardness for 3D printing customized flatfoot
cellulose nanofibril/casein-based 3D composite hemostasis orthosis. Biomater Sci, 11(5): 1692–1703.
scaffold for potential wound-healing application. ACS Appl
Mater Interfaces, 14(3): 3792–3808. 133. Choi H, Seo A, Lee J, 2019, Mallet finger lattice casts using
3D printing. J Healthc Eng, 2019(2019): 4765043.
121. Phang SJ, Arumugam B, Kuppusamy UR, et al., 2021,
A review of diabetic wound models-Novel insights into 134. Gelain F, Luo Z, Zhang S, 2020, Self-assembling peptide
diabetic foot ulcer. J Tissue Eng Regen Med, 15(12): 1051– EAK16 and RADA16 nanofiber scaffold hydrogel. Chem
1068. Rev, 120(24): 13434–13460.
122. Kim BS, Ahn M, Cho WW, et al., 2021, Engineering of 135. Cao W, Peng S, Yao Y, et al., 2022, A nanofibrous membrane
diseased human skin equivalent using 3D cell printing for loaded with doxycycline and printed with conductive
representing pathophysiological hallmarks of type 2 diabetes hydrogel strips promotes diabetic wound healing in vivo.
in vitro. Biomaterials, 272(2021): 120776. Acta Biomater, 152(2022): 60–73.
123. Lan CC, Wu CS, Huang SM, et al., 2012, High-glucose 136. Manso GMDC, Elias-Oliveira J, Guimarães JB, et al., 2023,
environment reduces human β-defensin-2 expression in Xenogeneic mesenchymal stem cell biocurative improves
human keratinocytes: Implications for poor diabetic wound skin wounds healing in diabetic mice by increasing mast
healing. Br J Dermatol, 166(6): 1221–1229. cells and the regenerative profile. Regen Ther, 22(2023):
124. Intini C, Elviri L, Cabral J, et al., 2018, 3D-printed chitosan- 79–89.
based scaffolds: An in vitro study of human skin cell growth 137. Dong Y, Rodrigues M, Kwon SH, et al., 2018, Acceleration
and an in-vivo wound healing evaluation in experimental of diabetic wound regeneration using an in situ-formed
diabetes in rats. Carbohydr Polym, 199(2018): 593–602. stem-cell-based skin substitute. Adv Healthc Mater, 7(17):
125. Wu M, Zhang Y, Huang H, et al., 2020, Assisted 3D printing e1800432.
of microneedle patches for minimally invasive glucose 138. Yastı AÇ, Akgun AE, Surel AA, et al., 2023, Graft of 3D
control in diabetes. Mater Sci Eng C Mater Biol Appl, bioprinted autologous minimally manipulated homologous
117(2020): 111299. adipose tissue for the treatment of diabetic foot ulcer.
126. Economidou SN, Pere CPP, Reid A, et al., 2019, 3D printed Wounds, 35(1): E22–E28.
microneedle patches using stereolithography (SLA) for 139. Bajuri MY, Kim J, Yu Y, et al., 2023, New paradigm in
intradermal insulin delivery. Mater Sci Eng C Mater Biol diabetic foot ulcer grafting techniques using 3D-bioprinted
Appl, 102(2019): 743–755. autologous minimally manipulated homologous adipose
127. Kamel R, El-Batanony R, Salama A, 2019, Pioglitazone- tissue (3D-AMHAT) with fibrin gel acting as a biodegradable
loaded three-dimensional composite polymeric scaffolds: scaffold. Gels, 9(1): 66.
A proof of concept study in wounded diabetic rats. Int J 140. Kesavan R, Sheela Sasikumar C, Narayanamurthy VB,
Pharm, 570(2019): 118667.
et al., 2021, Management of diabetic foot ulcer with MA-ECM
128. Chen TY, Wen TK, Dai NT, et al., 2021, Cryogel/hydrogel (minimally manipulated autologous extracellular matrix)
biomaterials and acupuncture combined to promote using 3D bioprinting technology - An innovative approach.
diabetic skin wound healing through immunomodulation. Int J Low Extrem Wounds, 0 (0): 15347346211045625.
Biomaterials, 269(2021): 120608. doi:10.1177/15347346211045625
129. Crews RT, Candela J, 2018, Decreasing an offloading device’s 141. Armstrong DG, Harris SG, Rasor Z, et al., 2022, Autologous
size and offsetting its imposed limb-length discrepancy lead to minimally manipulated homologous adipose tissue
improved comfort and gait. Diabetes Care, 41(7): 1400–1405. (AMHAT) for treatment of nonhealing diabetic foot ulcers.
130. Potier L, François M, Dardari D, et al., 2020, Comparison Plast Reconstr Surg Glob Open, 10(10): e4588.
of a new versus standard removable offloading device in 142. Bernal PN, Bouwmeester M, Madrid-Wolff J, et al., 2022,
patients with neuropathic diabetic foot ulcers: A French Volumetric bioprinting of organoids and optically tuned
national, multicentre, open-label randomized, controlled hydrogels to build liver-like metabolic biofactories. Adv
trial. BMJ Open Diabetes Res Care, 8(1): e000954. Mater, 34(15): e2110054.

Volume 9 Issue 6 (2023) 237 https://doi.org/10.36922/ijb.0142